TOP STORIES

• BUSINESS Chugai’s 2019 Earnings Renews Record for Third Year on Hemlibra, Tecentriq
  January 31, 2020

• REGULATORY Takeda’s RCC Drug Cabometyx Now in Line for March Approval; Alecensa, Rozlytrek Opdivo and More
  January 30, 2020

• REGULATORY Japan Ups Responses against Wuhan Coronavirus as First Domestic Transmission Confirmed
  January 29, 2020

• INTERVIEW “Excessive Self-Restraint” of Promotion Activities by Drug Makers Hindering Drugs’ Lifecycle Management: Physician
  January 28, 2020

• REGULATORY Discussions on Off-Year Re-Pricing to Begin in Spring, Focus on Scope of Drugs, Impact on Stakeholders: MHLW Bureau Chief
  January 27, 2020

• REGULATORY ICH’s Guidelines Helped Bring NDMA Contamination Problem to Light: NIHS Officials
  January 24, 2020

• REGULATORY Nasal Steroid Used as “Reference Drug” for Xolair in Special Re-Pricing
  January 23, 2020

• REGULATORY Get Serious about Reviewing Scope of Health Coverage, Says MOF Budget Examiner
  January 22, 2020

• REGULATORY Japan’s Special Re-Pricing Rules to Hit 17 Drugs in April; Potentially Big Slash for Keytruda, Lixiana
  January 22, 2020

• REGULATORY Xolair Faces New Special Re-Pricing Rule; Keytruda, Lixiana Caught by Huge-Seller Price Slash
  January 21, 2020

• BUSINESS Keytruda Snags Best-Seller Title in 2019 Drug Ranking: Encise
  January 20, 2020

• BUSINESS Xolair’s Use Would Be Limited to 1-3% of Pollen Allergy Patients in Japan: Specialist
  January 20, 2020

• REGULATORY MHLW Bureau Chief Says Delay Would Be Inevitable to Revise Drug Distribution Guidelines as Bid-Rigging Probe Continues
  January 17, 2020

• ACADEMIA Impact of Oligonucleotides - 1: Onpattro a Major Advance in FAP Treatment, but Challenges Remain
  January 16, 2020

• BUSINESS Tapped as Next Mitsubishi Tanabe Chief, Hiroaki Ueno Vows to Enrich Pipeline, Accelerate Global Biz
  January 15, 2020

• BUSINESS Astellas, Adaptimmune Hook Up on Off-the-Shelf Cell Therapies
  January 15, 2020

• REGULATORY Japan Likely to Take Pass on Rewarding Formulary Initiatives under Medical Fee Schedule
  January 14, 2020

• BUSINESS Meiji Gains Japan Rights for Novel Blood Cancer Treatment from HUYA Bioscience
  January 10, 2020

• BUSINESS Keytruda Top New Sales Generator in 2020, Enhertu Seen as Biggest Arrival: Evaluate
  January 9, 2020

• BUSINESS Daiichi Sankyo’s Blockbuster Hopeful Enhertu Hits US Market
  January 8, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 93
• 94
• 95
• 96
• 97
• 98
• 99
• 100
• 101
• …
• Next ›
• 最終 »